EHealth Research Development from 2010 to 2025

EHTH Stock  USD 7.25  0.14  1.89%   
EHealth's Research Development is increasing with slightly volatile movements from year to year. Research Development is predicted to flatten to about 38.1 M. For the period between 2010 and 2025, EHealth, Research Development quarterly trend regression had mean deviation of  16,572,082 and range of 76.3 M. View All Fundamentals
 
Research Development  
First Reported
2004-03-31
Previous Quarter
12.3 M
Current Value
14.9 M
Quarterly Volatility
12.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.5 M, Interest Expense of 11.7 M or Selling General Administrative of 49 M, as well as many indicators such as Price To Sales Ratio of 0.49, Dividend Yield of 0.0138 or PTB Ratio of 0.45. EHealth financial statements analysis is a perfect complement when working with EHealth Valuation or Volatility modules.
  
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

Latest EHealth's Research Development Growth Pattern

Below is the plot of the Research Development of eHealth over the last few years. It is EHealth's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EHealth's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

EHealth Research Development Regression Statistics

Arithmetic Mean42,808,724
Geometric Mean37,351,942
Coefficient Of Variation48.96
Mean Deviation16,572,082
Median38,058,585
Standard Deviation20,958,426
Sample Variance439.3T
Range76.3M
R-Value0.74
Mean Square Error212.9T
R-Squared0.55
Significance0
Slope3,257,688
Total Sum of Squares6588.8T

EHealth Research Development History

202538.1 M
202453.5 M
202361 M
202278.8 M
202183.8 M
202065.2 M
201947.1 M

About EHealth Financial Statements

Investors use fundamental indicators, such as EHealth's Research Development, to determine how well the company is positioned to perform in the future. Although EHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development53.5 M38.1 M

Currently Active Assets on Macroaxis

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.976
Earnings Share
(1.14)
Revenue Per Share
18.149
Quarterly Revenue Growth
0.273
Return On Assets
0.0182
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.